Martine Klausmann

625 total citations
19 papers, 269 citations indexed

About

Martine Klausmann is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Martine Klausmann has authored 19 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Martine Klausmann's work include Acute Myeloid Leukemia Research (5 papers), Blood disorders and treatments (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Martine Klausmann is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Blood disorders and treatments (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Martine Klausmann collaborates with scholars based in Germany. Martine Klausmann's co-authors include Oliver G. Ottmann, W. Lorenz, G. Seipelt, Eduard M. Walthers, Rudolf Weide, K. Ehlenz, A Lindemann, S Falk, P. Meusers and Arnold Ganser and has published in prestigious journals such as Blood, Lung Cancer and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

Martine Klausmann

19 papers receiving 255 citations

Peers

Martine Klausmann
Diego Quinones Raffo United States
Raquel Ríos United States
G.W. Dewald United States
L Broeders Netherlands
S. Fenu Italy
Diego Quinones Raffo United States
Martine Klausmann
Citations per year, relative to Martine Klausmann Martine Klausmann (= 1×) peers Diego Quinones Raffo

Countries citing papers authored by Martine Klausmann

Since Specialization
Citations

This map shows the geographic impact of Martine Klausmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine Klausmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine Klausmann more than expected).

Fields of papers citing papers by Martine Klausmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine Klausmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine Klausmann. The network helps show where Martine Klausmann may publish in the future.

Co-authorship network of co-authors of Martine Klausmann

This figure shows the co-authorship network connecting the top 25 collaborators of Martine Klausmann. A scholar is included among the top collaborators of Martine Klausmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine Klausmann. Martine Klausmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Tresckow, Julia von, Sandra Robrecht, Ali Aldaoud, et al.. (2023). Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group. Annals of Hematology. 102(11). 3083–3090. 4 indexed citations
2.
Bauhofer, Artur, et al.. (2021). Benefits of immunoglobulin substitution in primary and secondary immunodeficiencies: Interim analysis of a prospective, long-term non-interventional study. International Journal of Clinical Pharmacology and Therapeutics. 59(6). 417–427. 2 indexed citations
3.
Kubasch, Anne Sophie, Jens Kisro, H. Schulz, et al.. (2020). Disease management of patients with immune thrombocytopenia—results of a representative retrospective survey in Germany. Annals of Hematology. 99(9). 2085–2093. 4 indexed citations
4.
Weide, Rudolf, Roland Schnell, Michael Koenigsmann, et al.. (2020). Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement. BMC Immunology. 21(1). 39–39. 3 indexed citations
6.
Zaiß, Matthias, Christoph Losem, Stephan Schmitz, et al.. (2018). Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study). European Journal Of Haematology. 101(6). 766–773. 8 indexed citations
8.
Hofmann, W.-K., G. Seipelt, Oliver G. Ottmann, et al.. (2000). Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor α levels. Annals of Hematology. 79(5). 255–258. 20 indexed citations
9.
Lorenz, W., et al.. (1996). Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b. Annals of Hematology. 72(1). 41–43. 5 indexed citations
10.
Weide, Rudolf, et al.. (1996). Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b. Annals of Hematology. 72(1). 41–43. 61 indexed citations
11.
Kaiser, Ulrich, Martine Klausmann, Gerald Kolb, Karl-Heinz Pflüger, & K. Havemann. (1992). Felty’s Syndrome: Favorable Response to Granulocyte-Macrophage Colony-Stimulating Factor in the Acute Phase. Acta Haematologica. 87(4). 190–194. 3 indexed citations
12.
Köppler, H., Karl-Heinz Pflüger, Martine Klausmann, & K. Havemann. (1992). High-Dose Cyclophosphamide, Etoposide and BCNU with Non-Cryopreserved Autologous Bone Marrow Transplantation for Poor Prognosis Malignant Lymphoma. Leukemia & lymphoma. 6(3). 219–222. 3 indexed citations
13.
Havemann, K., Martine Klausmann, M. Wolf, et al.. (1991). Effect of rhGM-CSF on haematopoietic reconstitution after chemotherapy in small-cell lung cancer. Journal of Cancer Research and Clinical Oncology. 117(S4). S203–S207. 6 indexed citations
14.
Klausmann, Martine, et al.. (1991). Influence of GM-CSF-schedule on post-chemotherapy myelosuppression. Lung Cancer. 7. 141–141. 3 indexed citations
15.
Ganser, Arnold, A Lindemann, G. Seipelt, et al.. (1990). Effects of recombinant human interleukin-3 in aplastic anemia. Blood. 76(7). 1287–1292. 94 indexed citations
16.
Klausmann, Martine, et al.. (1989). Granulocyte-macrophage colony-stimulating factor binding sites and oxidative metabolism in human granulocytes. Annals of Hematology. 59(6). 486–492. 2 indexed citations
17.
Klausmann, Martine, et al.. (1988). Influence of recombinant human granulocyte-macrophage colony-stimulating factor on granulocyte functions.. PubMed. 265–9. 7 indexed citations
18.
Klausmann, Martine, et al.. (1988). Modulation of functions of granulocytes by recombinant human GM-CSF and possible complications of GM-CSF therapy.. PubMed. 2(12 Suppl). 63S–72S. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026